Title |
Maintenance of genome stability by Fanconi anemia proteins
|
---|---|
Published in |
Cell & Bioscience, February 2017
|
DOI | 10.1186/s13578-016-0134-2 |
Pubmed ID | |
Authors |
Anna Palovcak, Wenjun Liu, Fenghua Yuan, Yanbin Zhang |
Abstract |
Persistent dysregulation of the DNA damage response and repair in cells causes genomic instability. The resulting genetic changes permit alterations in growth and proliferation observed in virtually all cancers. However, an unstable genome can serve as a double-edged sword by providing survival advantages in the ability to evade checkpoint signaling, but also creating vulnerabilities through dependency on alternative genomic maintenance factors. The Fanconi anemia pathway comprises an intricate network of DNA damage signaling and repair that are critical for protection against genomic instability. The importance of this pathway is underlined by the severity of the cancer predisposing syndrome Fanconi anemia which can be caused by biallelic mutations in any one of the 21 genes known thus far. This review delineates the roles of the Fanconi anemia pathway and the molecular actions of Fanconi anemia proteins in confronting replicative, oxidative, and mitotic stress. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 96 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 27 | 28% |
Researcher | 15 | 16% |
Student > Master | 10 | 10% |
Student > Bachelor | 5 | 5% |
Student > Doctoral Student | 4 | 4% |
Other | 18 | 19% |
Unknown | 17 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 48 | 50% |
Agricultural and Biological Sciences | 12 | 13% |
Medicine and Dentistry | 10 | 10% |
Unspecified | 2 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
Other | 4 | 4% |
Unknown | 19 | 20% |